Categories: News

Lumeon Announces Appointment of John Glaser to Board of Directors as Non-Executive Director

BOSTON–(BUSINESS WIRE)–Lumeon, a leader in care journey orchestration, today announced the appointment of John Glaser to the Lumeon Board of Directors. Glaser will serve as an independent non-executive director and support Lumeon’s continued growth in helping healthcare systems develop and scale new delivery models.

“We are delighted to welcome John to our board,” said Lumeon Founder and CEO Robbie Hughes. “From his vantage point as a former CIO, vendor, a thought leader, and visionary, John brings a unique perspective on the potential to transform care delivery with scalable, automated care solutions that build on existing EHR and analytics investments. There has never been a greater need to focus on productivity and process improvement to relieve the burden on today’s overwhelmed care teams.”

“COVID has hit providers hard with disruptions to their business model, but a lack of key clinical staffing has compromised recovery,” Hughes continued. “While many vendors are helping with revenue cycle or other administrative tasks, only Lumeon effectively augments the front-line clinical teams to make a real impact on care delivery. With John’s support, Lumeon is uniquely positioned to transform how providers think about the tools at their disposal to respond to the challenges they face today and tomorrow.”

Glaser served as Senior Vice President of Population Health at Cerner; Chief Executive Officer of Siemens Heath Services; and Chief Information Officer at Partners HealthCare. He is an Executive-in-Residence at the Harvard Medical School, a Lecturer at the Wharton School, and a Board Member for several digital health companies.

“The relentless move to value-based care places significant pressure on healthcare providers and payers to streamline their clinical, administrative, and financial processes. Processes such as case management, perioperative scheduling, and population health management form the backbone of care delivery and management in the post-pandemic era,” said Glaser. “Lumeon’s sophisticated process automation technology and services enable customers to deliver exceptional, standardized and personalized care. I am delighted to join the Lumeon team.”

“I’ve known John for most of our careers, both as a customer, a leader, and a competitor, and am delighted to welcome him to the Lumeon Board,” said Tom Zajac, Executive Chairman and Chairman of the Board. “John has been at the forefront of health transformation. As the industry model continues to evolve outside the four walls of the hospital – to community and consumer-focused value-based care – he will bring deep experience, insight, and commitment to help Lumeon deliver solutions that drive better care for all stakeholders.”

About Lumeon

The leader in care journey orchestration, Lumeon delivers intelligent automation to transform how care is delivered – improving financial, clinical and human outcomes for health organizations, their care teams, and their patients.

Lumeon’s award-winning technology platform proactively navigates patients along a personalized adaptive care plan, by automating care processes, tasks, and adherence monitoring, providing actionable insights and augmenting care decisions, and coordinating care team communication and action to ensure seamless and predictable care delivery across every care setting.

Partnering with more than 70 innovative health organizations in the U.S. and Europe, Lumeon’s solutions address the needs of hospitals, payers, ambulatory care, and population health, empowering care teams to operate at the top of their license, reducing costs for providers, and creating the coordinated and convenient digital experiences that patients and care teams deserve – ensuring the right care every time for every patient.

Contacts

Evan Neville

lumeon@walkersands.com
617-960-8912

Staff

Recent Posts

Waystar announces term loan repricing and credit rating upgrades from Fitch, Moody’s, and S&P Global

Reduces Waystar's cost of capital and enhances its ability to allocate free cash flow towards…

10 hours ago

NUTEX HEALTH ANNOUNCES 1-FOR-10 REVERSE STOCK SPLIT

HOUSTON, June 27, 2024 /PRNewswire/ -- Nutex Health Inc. ("Nutex Health" or the "Company") (NASDAQ:…

10 hours ago

Chroma Medicine Announces Exclusive License Agreement with the Whitehead Institute for Novel Epigenetic Editing Technology

License provides exclusive access to innovative epigenetic editors and expands the reach of Chroma's platform…

10 hours ago

Pulmonary Fibrosis Foundation’s 2024 PFF Walk Raises Funds Toward a Cure

Nationwide Walk Series Kicks Off July 20 in Pittsburgh CHICAGO, June 27, 2024 /PRNewswire/ --…

10 hours ago

Zoi Capital Founders and Industry Veterans Announce 200 Million Dollar Fund Targeting AI Technologies with Practical Applications for Healthcare

The Venture Capital Firm Set to Expand Investments in Innovative Healthcare Companies NEW YORK, June…

10 hours ago